Cargando…

Genomic landscape of metastatic colorectal cancer

Response to drug therapy in individual colorectal cancer (CRC) patients is associated with tumour biology. Here we describe the genomic landscape of tumour samples of a homogeneous well-annotated series of patients with metastatic CRC (mCRC) of two phase III clinical trials, CAIRO and CAIRO2. DNA co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haan, Josien C., Labots, Mariette, Rausch, Christian, Koopman, Miriam, Tol, Jolien, Mekenkamp, Leonie J. M., van de Wiel, Mark A., Israeli, Danielle, van Essen, Hendrik F., van Grieken, Nicole C. T., Voorham, Quirinus J. M., Bosch, Linda J. W., Qu, Xueping, Kabbarah, Omar, Verheul, Henk M. W., Nagtegaal, Iris D., Punt, Cornelis J. A., Ylstra, Bauke, Meijer, Gerrit A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Pub. Group 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4243240/ https://www.ncbi.nlm.nih.gov/pubmed/25394515 http://dx.doi.org/10.1038/ncomms6457

Ejemplares similares

Chromosomal Copy Number Aberrations in Colorectal Metastases Resemble Their Primary Counterparts and Differences Are Typically Non-Recurrent
por: Mekenkamp, Leonie J. M., et al.
Publicado: (2014)

Decoy receptor 1 (DCR1) promoter hypermethylation and response to irinotecan in metastatic colorectal cancer
por: Bosch, Linda J.W., et al.
Publicado: (2017)

Reduced rate of copy number aberrations in mucinous colorectal carcinoma
por: Hugen, Niek, et al.
Publicado: (2015)

Synoptic reporting increases quality of upper gastrointestinal cancer pathology reports
por: Baranov, Nikolaj S., et al.
Publicado: (2019)

High Prevalence and Clinical Relevance of Genes Affected by Chromosomal Breaks in Colorectal Cancer
por: van den Broek, Evert, et al.
Publicado: (2015)

Clinicopathological features and outcome in advanced colorectal cancer patients with synchronous vs metachronous metastases
por: Mekenkamp, L J M, et al.
Publicado: (2010)

Predictive value of chromosome 18q11.2‐q12.1 loss for benefit from bevacizumab in metastatic colorectal cancer: A post hoc analysis of the randomized phase III‐trial AGITG‐MAX
por: van Dijk, Erik, et al.
Publicado: (2022)

Beyond KRAS mutation status: influence of KRAS copy number status and microRNAs on clinical outcome to cetuximab in metastatic colorectal cancer patients
por: Mekenkamp, Leonie JM, et al.
Publicado: (2012)

Normalized, Segmented or Called aCGH Data?
por: van Wieringen, Wessel N., et al.
Publicado: (2007)

GeneBreak: detection of recurrent DNA copy number aberration-associated chromosomal breakpoints within genes
por: van den Broek, Evert, et al.
Publicado: (2017)

MicroRNA-143 is a putative predictive factor for the response to fluoropyrimidine-based chemotherapy in patients with metastatic colorectal cancer
por: Simmer, Femke, et al.
Publicado: (2015)

Comprehensive Mutation Analysis in Colorectal Flat Adenomas
por: Voorham, Quirinus J. M., et al.
Publicado: (2012)

Nationwide implementation of a multifaceted tailored strategy to improve uptake of standardized structured reporting in pathology: an effect and process evaluation
por: Swillens, Julie E. M., et al.
Publicado: (2022)

Umbilical metastases: Real‐world data shows abysmal outcome
por: Hugen, Niek, et al.
Publicado: (2021)

Mitochondrial microsatellite instability in patients with metastatic colorectal cancer
por: Venderbosch, S., et al.
Publicado: (2015)

FocalCall: An R Package for the Annotation of Focal Copy Number Aberrations
por: Krijgsman, Oscar, et al.
Publicado: (2014)

KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients
por: Knijn, N, et al.
Publicado: (2011)

EMAST Is Associated with a Poor Prognosis in Microsatellite Instable Metastatic Colorectal Cancer
por: Venderbosch, Sabine, et al.
Publicado: (2015)

Intensity-based analysis of dual-color gene expression data as an alternative to ratio-based analysis to enhance reproducibility
por: Bossers, Koen, et al.
Publicado: (2010)

The value of case reports in rare oncological scenarios: mixed method analysis of colorectal metastases from breast cancer
por: Nagtegaal, I. D., et al.
Publicado: (2023)

MiR expression profiles of paired primary colorectal cancer and metastases by next-generation sequencing
por: Neerincx, M, et al.
Publicado: (2015)

Nationwide evaluation of mutation-tailored anti-EGFR therapy selection in patients with colorectal cancer in daily clinical practice
por: Steeghs, Elisabeth M P, et al.
Publicado: (2022)

CGHpower: exploring sample size calculations for chromosomal copy number experiments
por: Scheinin, Ilari, et al.
Publicado: (2010)

High-Dose Intermittent Treatment with the Multikinase Inhibitor Sunitinib Leads to High Intra-Tumor Drug Exposure in Patients with Advanced Solid Tumors
por: Gerritse, Sophie L., et al.
Publicado: (2022)

High sensitivity of both sequencing and real-time PCR analysis of KRAS mutations in colorectal cancer tissue
por: Tol, Jolien, et al.
Publicado: (2010)

Clonal Patterns Between Pouch Neoplasia and Prior Colorectal Neoplasia in Inflammatory Bowel Disease Patients: An Exploratory Cohort Study
por: te Groen, Maarten, et al.
Publicado: (2023)

Combination of a six microRNA expression profile with four clinicopathological factors for response prediction of systemic treatment in patients with advanced colorectal cancer
por: Neerincx, Maarten, et al.
Publicado: (2018)

Deficient mismatch repair system in patients with sporadic advanced colorectal cancer
por: Koopman, M, et al.
Publicado: (2009)

Promoter methylation of Wnt-antagonists in polypoid and nonpolypoid colorectal adenomas
por: Voorham, Quirinus JM, et al.
Publicado: (2013)

High resolution analysis of DNA copy-number aberrations of chromosomes 8, 13, and 20 in gastric cancers
por: Buffart, Tineke E., et al.
Publicado: (2009)

Nationwide differences in cytology fixation and processing methods and their impact on interlaboratory variation in PD-L1 positivity
por: Koomen, Bregje M., et al.
Publicado: (2022)

Matching of array CGH and gene expression microarray features for the purpose of integrative genomic analyses
por: van Wieringen, Wessel N, et al.
Publicado: (2012)

Marie Curie – Genome Architecture in Relation to Disease
por: Ylstra, Bauke
Publicado: (2007)

Selection of Protein Kinase Inhibitors Based on Tumor Tissue Kinase Activity Profiles in Patients with Refractory Solid Malignancies: An Interventional Molecular Profiling Study
por: Labots, Mariette, et al.
Publicado: (2018)

Anti-proliferative action of vitamin D in MCF7 is still active after siRNA-VDR knock-down
por: Costa, José L, et al.
Publicado: (2009)

NMD inhibition fails to identify tumour suppressor genes in microsatellite stable gastric cancer cell lines
por: Buffart, Tineke E, et al.
Publicado: (2009)

Increased Expression of Matrix Extracellular Phosphoglycoprotein (MEPE) in Cortical Bone of the Rat Tibia after Mechanical Loading: Identification by Oligonucleotide Microarray
por: Reijnders, Christianne M. A., et al.
Publicado: (2013)

Reduced genomic tumor heterogeneity after neoadjuvant chemotherapy is related to favorable outcome in patients with esophageal adenocarcinoma
por: Obulkasim, Askar, et al.
Publicado: (2016)

Cervical intraepithelial neoplasia and the risk of spontaneous preterm birth: A Dutch population-based cohort study with 45,259 pregnancy outcomes
por: Loopik, Diede L., et al.
Publicado: (2021)

HPV type-related chromosomal profiles in high-grade cervical intraepithelial neoplasia
por: Bierkens, Mariska, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_v54vpavpqn40la8ctf5gpqrkt5